News
6h
Zacks Investment Research on MSNCan LLY's Next-Generation Obesity Pipeline Fuel Further Growth?Eli Lilly LLY has experienced significant growth in the past few years, particularly driven by the success of its popular ...
Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for ...
Phase 3 REDEFINE 1 trial found that treatment with CagriSema led to a 22.7% weight loss at 68 weeks among patients who adhered to the treatment, compared ...
Top Alternatives to Ozempic That Are EffectiveReviewed by Dr. Craig Primack, MD, FACP, FAAP, FOMAOzempic is a medication ...
Hims & Hers (HIMS) defends recovery with personalized healthcare adoption, GLP-1 partnerships, and profit growth. Click here ...
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition By Annika Kim Constantino, CNBC and Ashley Capoot, CNBC • Published June 11, 2025 • Updated on June 11, 2025 at 2 ...
Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s Disruptor 50 List.
Don’t be persuaded by the abundance of propaganda you see in ads, newspapers, magazines, TV, and the Internet. There is no magic fix!
Emperador president and CEO Winston Co on Monday admitted the global liquor industry “has been challenging for a few quarters,” although the whisky segment was “much more stable and ...
MANILA, Philippines — In its Regional Market Outlook for the second half of the year, Singapore’s DBS Bank maintained its 6,900 year-end target for the benchmark Philippine Stock Exchange Index ...
Wegovy Helped With Waistline but Not at Higher Dose “I’m taking Wegovy. I did really well — until I hit the higher dose. Then I felt sick. No mood change. I lost 6 inches on my waist. I also worked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results